RLJ-NE-299A: A new plant based vaccine adjuvant

Vaccine

Volumn 25, Issue 14, 2007, Pages 2706-2715

  Khajuria, Anamika ^a   Gupta, Amit ^a   Singh, Surjeet ^a   Malik, Fayaz ^a   Singh, Jaswant ^a   Suri, K A ^a   Satti, N K ^a   Qazi, G N ^a   Srinivas, V K ^b   Gopinathan, ^b   Ella, Krishna ^b  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b Bharat Biotech International Limited   (India)

Author keywords

Cellular; Hepatitis B surface antigen; Humoral; Picrorhiza kurroa

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HERBACEOUS AGENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; RLJ NE 299A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG TOLERABILITY; HEPATITIS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; PICRORHIZA KURROA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TH1 CELL; TH2 CELL; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; IMMUNOGLOBULIN G; IRIDOIDS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PICRORHIZA; T-LYMPHOCYTES; VACCINES;

EID: 33947289443     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.036     Document Type: Article

References (22)

1. Chedid L. Adjuvants of immunity. Ann Immunol (Inst Pasteur) 136D (1985) 283
2. Glenny A.T., Buttle G.A.H., and Stevens M.F. Rate of disappearance of diphtheria toxoid injected into rabbits and guinea pigs: toxoid precipitated with alum. J Pathol Bacteriol 34 (1926) 267
3. Aprile M.A., and Wardlaw A.C. Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health 57 (1966) 343
4. Hyslop N.S., and Morrow A.W. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines. Res Vet Sci 10 (1969) 109
5. Koff W.C., and Glass M.J. Further direction in HIV vaccine development. AIDS Res Hum Retroviruses 8 (1992) 1313
6. Gupta R.K., Rost B.E., Relyveld E., Siber G., Powell M.F., Newmandand M.K., et al. Adjuvant properties of aluminum and calcium compounds. Vaccine design (1995), Plenum press, New York p. 229
7. Kirtikar K.R., and Basu B.D. Indian medicinal plants vol. III (1935), Lalit Mohan Basu, Allahabad p. 1825-1826
8. Dey A.C., Bhishen S., and Mahendra P.S. Indian medicinal plants used in ayurvedic preparations (1980), J Res Indian Med, Dehra Dun, India p. 81
9. Chaturvedi G.N., and Singh R.H. Jaundice of infectious hepatitis and its treatment with an indigenous drug Picrorhiza kurroa (a review of thirty cases and clinical trial). J Res Indian Med 1 (1966) 1-14
10. Handa S.S., Sharma A., and Chakraborti K.K. Natural products and plants as liver protecting drugs. Fitoterapia 58 (1986) 307-351
11. Dorsch W., Stuppner H., Wagner H., Gropp M., Demoulin S., Ring J., et al. Antiasthmatic effects of Picrorhiza kurroa, Androsin prevents allergen and PAV-induced bronchial obstruction in guinea pigs. Int Arch Allergy Appl Immunol 95 (1991) 128-133
12. Rajaram D. A preliminary clinical trial of Picrorhiza kurroa in bronchial asthma. Bombay Hosp J 18 (1976) 66-69
13. Mittal G.C., Saxena S., Kanchan S.K., Mangal O.P., Dandiya P.C., et al. Clinical trials of 'bibarin' in liver disorders with special reference to infective hepatitis. Indian Pract 8 (1978) 683-693
14. Kitagawa I., Hino K., Nishimura T., Iwata E., Yosioka I., et al. On the constituents of Picrorhiza kurroa. The structure of picroside I. Chem Pharm Bull 19 (1971) 2534-2544
15. Weinges K., Kloss P., and Henkels W.D. Picroside II, ein neues 6-vanilloyl-cataipolaus Picrorhiza kurroa Royle und Benth Liebigs. Ann Chem 759 (1972) 173-182
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 16 (1983) 55-63
17. Plumb J.A., Milroy R., and Kaye S.B. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 49 (1989) 4435-4440
18. Stoute J.A., Slaoui M., and Heppner D.G. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria: RTS, S malaria vaccine evaluation group. N Engl J Med 336 (1997) 86-91
19. Sharma M.L., Rao C.S., and Duda P.L. Immunostimulatory activity of Picrorhiza kurroa leaf extract. J Ethnopharmacol 41 (1994) 185-192
20. Khajuria A, Gupta A, Singh S, Malik F, Singh J, Bedi KL, et al. A plant based vaccine adjuvant. Patent submitted in India as well as abroad.
21. Gupta R.K., Relyveld E.H., Lindblad E.B., Bizzini B., Efraim B.S., and Gupta C.K. Adjuvants: a balance between toxicity and adjuvanticity. Vaccine 11 (1993) 293-306
22. Kovarik J., and Siegrist C.A. Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators. Immunol Cell Biol 76 (1998) 1440-1711